CAPRICOR THERAPEUTICS, INC. Cash Provided by (Used in) Financing Activities, Discontinued Operations
CAPRICOR THERAPEUTICS, INC. (CAPR) reported Cash Provided by (Used in) Financing Activities, Discontinued Operations of $933 for the 3-month period ending 2014-03-31, per its 10-Q filed 2014-05-15.
Discontinued › Cash Flow › Financing Activities
us-gaap:CashProvidedByUsedInFinancingActivitiesDiscontinuedOperations · last filed 2014-05-15
- CAPRICOR THERAPEUTICS, INC. cash provided by (used in) financing activities, discontinued operations for the quarter ending 2014-03-31 was $933.00, a 99.89% decline year-over-year.
- CAPRICOR THERAPEUTICS, INC. cash provided by (used in) financing activities, discontinued operations for the quarter ending 2013-03-31 was $857.27K.
- CAPRICOR THERAPEUTICS, INC. cash provided by (used in) financing activities, discontinued operations for fiscal 2013 was $3.93M, a 21.50% decline from fiscal 2012.
- CAPRICOR THERAPEUTICS, INC. cash provided by (used in) financing activities, discontinued operations for fiscal 2012 was $5.00M.
| Period end | Cash Provided by (Used in) Financing Activities, Discontinued Operations 3 month | Cash Provided by (Used in) Financing Activities, Discontinued Operations 12 month | Cash Provided by (Used in) Financing Activities, Discontinued Operations 102 month | Cash Provided by (Used in) Financing Activities, Discontinued Operations 105 month |
|---|---|---|---|---|
| 2014-03-31 | $933.00 10-Q · filed 2014-05-15 | $15.64M 10-Q · filed 2014-05-15 | ||
| 2013-12-31 | $3.93M 10-K · filed 2014-03-31 | $15.64M 10-K · filed 2014-03-31 | ||
| 2013-03-31 | $857.27K 10-Q · filed 2014-05-15 | |||
| 2012-12-31 | $5.00M 10-K · filed 2014-03-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PUMA BIOTECHNOLOGY, INC. (PBYI) | United States | $0.507B | 15.53 |
| ARVINAS, INC. (ARVN) | United States | $0.510B | 58.38 |
| Ovid Therapeutics Inc. (OVID) | United States | $0.487B | -14.41 |
| ASSEMBLY BIOSCIENCES, INC. (ASMB) | United States | $0.481B | -13,053.96 |
| Evolus, Inc. (EOLS) | United States | $0.519B | -13.32 |
| CRESCENT BIOPHARMA, INC. (CBIO) | United States | $0.529B | -5.20 |
| Indaptus Therapeutics, Inc. (INDP) | United States | $0.537B | |
| MapLight Therapeutics, Inc. (MPLT) | United States | $0.459B | -7.10 |
| Quoin Pharmaceuticals Ltd. (QNRX) | $0.443B | -17.85 | |
| CYPHERPUNK TECHNOLOGIES INC. (CYPH) | United States | $0.438B | -75.63 |